18-12-2017 09:30 via prnewswire.com

DelSiTech Ltd and C-Tri Co. Ltd Sign a Collaboration Agreement to Develop Innovative Drug Delivery Technology Product for Oncology

TURKU, Finland, December 18, 2017 /PRNewswire/ --DelSiTech Ltd, a Finnish drug delivery technology and development company, and C-Tri Co. Ltd, a Korean KOSDAQ listed biopharmaceutical company, have signed a Partnership and Collaboration Agreement to develop long-acting controlled...
Read more »